Development and dosimetry of (203)Pb/(212)Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?

PURPOSE: The aims of this study were to develop a prostate-specific membrane antigen (PSMA) ligand for labelling with different radioisotopes of lead and to obtain an approximation of the dosimetry of a simulated (212)Pb-based alpha therapy using its (203)Pb imaging analogue. METHODS: Four novel Glu...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, José Carlos, Schäfer, Martin, Bauder-Wüst, Ulrike, Lehnert, Wencke, Leotta, Karin, Morgenstern, Alfred, Kopka, Klaus, Haberkorn, Uwe, Mier, Walter, Kratochwil, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451745/
https://www.ncbi.nlm.nih.gov/pubmed/30603987
http://dx.doi.org/10.1007/s00259-018-4220-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451745/
https://www.ncbi.nlm.nih.gov/pubmed/30603987
http://dx.doi.org/10.1007/s00259-018-4220-z

Ejemplares similares